G-protein-coupled receptors and their (Bio) Chemical significance win 2012 nobel prize in chemistry

Biomedical Journal

Volumn 36, Issue 3, 2013, Pages 118-124

  Lin, Hsi Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

G protein; G protein coupled receptors; ligand; receptor desensitization; signaling pathway; structure

Indexed keywords

ADHESION CLASS G PROTEIN COUPLED RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ARRESTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GLUTAMATE CLASS G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE C; RHODOPSIN; RHODOPSIN CLASS G PROTEIN COUPLED RECEPTOR; SECRETIN CLASS G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

AWARDS AND PRIZES; BINDING AFFINITY; BIOCHEMISTRY; BIOLOGICAL MODEL; CELL MIGRATION; CELL SURFACE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; ENDOCYTOSIS; HUMAN; INTRACELLULAR SIGNALING; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; NOBEL PRIZE; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84881232356     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.113233     Document Type: Review

References (74)

1. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form fve main families. Phylogenetic analysis, paralogon groups, and fngerprints. Mol Pharmacol 2003;63:1256-72.
2. Kroeze WK, Sheffer DJ, Roth BL. G-protein-coupled receptors at a glance. J Cell Sci 2003;116:4867-9.
3. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002;3:639-50.
4. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and signifcance for drug discovery. Nat Rev Drug Discov 2008;7:339-57.
5. Tyndall JD, Sandilya R. GPCR agonists and antagonists in the clinic. Med Chem 2005;1:405-21.
6. Hausch F, Holsboer F. The seven pillars of molecular pharmacology: GPCR research honored with Nobel Prize for chemistry. Angew Chem Int Ed Engl 2012;51:12172-5.
7. Baker EN, Dauter Z. Nobel Prize for Chemistry 2012: GPCRs seen through a crystal ball. Acta Crystallogr D Biol Crystallogr 2012; 68: 1439-40.
8. Buchen L. Cell signalling: It's all about the structure. Nature 2011;476:387-90.
9. Lefkowitz RJ. Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 2004;25:413-22.
10. Lefkowitz RJ, Mukherjee C, Coverstone M, Caron MG. Stereospecifc (3H) (minus)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase. Biochem Biophys Res Commun 1974;60:703-9.
11. Lefkowitz RJ, Roth J, Pastan I. Radioreceptor assay of adrenocorticotropic hormone: New approach to assay of polypeptide hormones in plasma. Science 1970;170:633-5.
12. Lefkowitz RJ, Roth J, Pricer W, Pastan I. ACTH receptors in the adrenal: Specifc binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci USA 1970;65:745-52.
13. De Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 1980;255:7108-17.
14. Caron MG, Lefkowitz RJ. Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes. J Biol Chem 1976;251:2374-84.
15. Caron MG, Srinivasan Y, Pitha J, Kociolek K, Lefkowitz RJ. Affnity chromatography of the beta-adrenergic receptor. J Biol Chem 1979;254:2923-7.
16. Cerione RA, Sibley DR, Codina J, Benovic JL, Winslow J, Neer EJ, et al. Reconstitution of a hormone-sensitive adenylate cyclase system. The pure beta-adrenergic receptor and guanine nucleotide regulatory protein confer hormone responsiveness on the resolved catalytic unit. J Biol Chem 1984;259:9979-82.
17. Cerione RA, Strulovici B, Benovic JL, Strader CD, Caron MG, Lefkowitz RJ. Reconstitution of beta-adrenergic receptors in lipid vesicles: Affnity chromatography-purifed receptors confer catecholamine responsiveness on a heterologous adenylate cyclase system. Proc Natl Acad Sci USA 1983;80:4899-903.
18. Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, et al. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 1986;321:75-9.
19. Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RA, Keller P, et al. Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem 1987;262:7321-7.
20. Lefkowitz RJ. Seven transmembrane receptors: A brief personal retrospective. Biochim Biophys Acta 2007;1768:748-55.
21. Nathans J, Hogness DS. Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin. Cell 1983;34:807-14.
22. Stryer L. Cyclic GMP cascade of vision. Annu Rev Neurosci 1986;9:87-119.
23. Millar RP, Newton CL. The year in G protein-coupled receptor research. Mol Endocrinol 2010;24:261-74.
24. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ. Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specifcity. Science 1988;240:1310-6.
25. Cotecchia S, Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ. Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem 1992;267:1633-9.
26. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 1992;267:1430-3.
27. Rajagopal K, Lefkowitz RJ, Rockman HA. When 7 transmembrane receptors are not G protein-coupled receptors. J Clin Invest 2005;115:2971-4.
28. Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 2009;10:819-30.
29. Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ. Mutagenesis of the beta 2-adrenergic receptor: How structure elucidates function. Annu Rev Pharmacol Toxicol 1992;32:167-83.
30. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA. Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994;63:101-32.
31. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000;289:739-45.
32. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007;450:383-7.
33. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007;318:1258-65.
34. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007;318:1266-73.
35. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, et al. Structure of a nanobody-stabilized active state of the beta (2) adrenoceptor. Nature 2011;469:175-80.
36. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G-protein-coupled receptor target family. Chem Med Chem 2006;1:761-82.
37. Bockaert J, Pin JP Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J 1999;18:1723-9.
38. Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008;454:183-7.
39. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008;455:497-502.
40. Hanson MA, Stevens RC. Discovery of new GPCR biology: One receptor structure at a time. Structure 2009;17:8-14
41. Weis WI, Kobilka BK. Structural insights into G-protein-coupled receptor activation. Curr Opin Struct Biol 2008;18:734-40.
42. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-64.
43. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001;53:245-82.
44. Lappano R, Maggiolini M. G protein-coupled receptors: Novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011;10:47-60.
45. Congreve M, Marshall F. The impact of GPCR structures on pharmacology and structure-based drug design. Br J Pharmacol 2010;159:986-96.
46. Kenakin T. Agonist-receptor effcacy. II. Agonist traffcking of receptor signals. Trends Pharmacol Sci 1995;16:232-8.
47. Millar RP, Pawson AJ. Outside-in and inside-out signaling: The new concept that selectivity of ligand binding at the gonadotropin-releasing hormone receptor is modulated by the intracellular environment. Endocrinology 2004;145:3590-3.
48. Millar RP, Pawson AJ, Morgan K, Rissman EF, Lu ZL. Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front Neuroendocrinol 2008;29:17-35.
49. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007;7:79-94.
50. Goldsmith ZG, Dhanasekaran DN. G protein regulation of MAPK networks. Oncogene 2007;26:3122-42.
51. Caunt CJ, Finch AR, Sedgley KR, McArdle CA. Seven-transmembrane receptor signalling and ERK compartmentalization. Trends Endocrinol Metab 2006;17:276-83.
52. Wang K, Wong YH. G protein signaling controls the differentiation of multiple cell lineages. Biofactors 2009;35:232-8.
53. Belmonte SL, Blaxall BC. G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ Res 2011;109:309-19.
54. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 2004;27:107-44.
55. Violin JD, Lefkowitz RJ. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 2007;28:416-22.
56. Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by endocytic membrane traffcking and its potential implications. Annu Rev Pharmacol Toxicol 2008;48:537-68.
57. Bhola NE, Grandis JR. Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci 2008;13:1857-65.
58. Fischer OM, Hart S, Gschwind A, Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans 2003;31:1203-8.
59. Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005;6:32-43.
60. Short SM, Boyer JL, Juliano RL. Integrins regulate the linkage between upstream and downstream events in G protein-coupled receptor signaling to mitogen-activated protein kinase. J Biol Chem 2000;275:12970-7.
61. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007;25:619-47.
62. Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 2009;27:339-62.
63. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001;2:274-86.
64. Ferre S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, et al. Building a new conceptual framework for receptor heteromers. Nat Chem Biol 2009;5:131-4.
65. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, et al. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004;279:35671-8.
66. Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999;399:697-700.
67. Lee C, Ji I, Ryu K, Song Y, Conn PM, Ji TH. Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chem 2002;277:15795-800.
68. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, et al. GABA (B) receptors function as a heteromeric assembly of the subunits GABA (B) R1 and GABA (B) R2. Nature 1998;396:674-9.
69. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, et al. GABA (B)-receptor subtypes assemble into functional heteromeric complexes. Nature 1998;396:683-7.
70. Kuner R, Kohr G, Grunewald S, Eisenhardt G, Bach A, Kornau HC. Role of heteromer formation in GABAB receptor function. Science 1999;283:74-7.
71. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, et al. Heterodimerization is required for the formation of a functional GABA (B) receptor. Nature 1998;396:679-82.
72. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 1997;272:30603-6.
73. Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, Albar JP, Martinez AC, Mellado M. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci USA 1999;96:3628-33.
74. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport and ligand specifcity of the calcitonin-receptor- like receptor. Nature 1998;393:333-9.